help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warshaw, M. L.
Right arrow Articles by Gibori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warshaw, M. L.
Right arrow Articles by Gibori, G.

Endocrinology, Vol 119, 2642-2648, Copyright © 1986 by Endocrine Society


ARTICLES

Placental secretion of androgens in the rat

ML Warshaw, DC Johnson, I Khan, B Eckstein and G Gibori

In contrast to the human placenta, which does not secrete androgens, the rat placenta synthesizes significant amounts of these steroids. The purpose of this study was to determine why the rat placenta does not secrete androgens before day 12 of pregnancy, to ascertain whether the rat placenta secretes more androstenedione than testosterone, to compare the capacity of luteal and placental tissue to secrete androgen, and to determine whether the rat placental produces androstenedione via the delta 4- or delta 5-steroidogenic pathway. To determine whether the inability of the rat placenta to produce androstenedione before midpregnancy was due to the absence of active 17 alpha-hydroxylase and 17,20-lyase enzymes and also to investigate the ontogeny of both placental production of androstenedione and enzyme activities, placentas were isolated from rats between days 8-21 of pregnancy and either incubated or used to determine the activities of 17 alpha-hydroxylase and 17,20-lyase. Before day 11, enzyme activity was not detectable. From day 11, both enzyme activities and placental secretion of androstenedione steadily increased to peak values by day 18 and declined just before parturition. To investigate the principal aromatizable androgen secreted both in vivo and in vitro approaches were used. Levels of androstenedione and testosterone found in the uterine vein as well as those produced by placental tissue were determined. Rat placentas secreted markedly more androstenedione than testosterone, both in vivo and in vitro. When placental and luteal secretion of androstenedione and testosterone were compared, it was found that luteal tissue had a higher capacity for androgen synthesis than did the placenta. Yet, because of its greater mass, each placenta secreted 15 times more androstenedione and 4.5 times more testosterone than each corpus luteum. To determine the preferential usage of progesterone or pregnenolone as substrate by the placenta, [14C] progesterone and [3H]pregnenolone were added in equimolar concentrations. The resulting 14C to 3H ratio of the androgen produced indicates that the preferred substrate is progesterone. In summary, results of this investigation describe, for the first time, the development of 17 alpha-hydroxylase and 17,20-lyase activities in the rat placenta and demonstrate that the placenta does not produce androgen before day 11 due to the absence of active enzymes. The results further demonstrate that the rat placenta secretes significantly more androstenedione that testosterone both in vivo and in vitro, produces more androgen than the corpus luteum because of its greater mass, and forms its androgen primarily via the delta 4-st


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. R. Bair and S. H. Mellon
Deletion of the Mouse P450c17 Gene Causes Early Embryonic Lethality
Mol. Cell. Biol., June 15, 2004; 24(12): 5383 - 5390.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. G. Timms, R. E. Peterson, and F. S. vom Saal
2,3,7,8-Tetrachlorodibenzo-p-dioxin Interacts with Endogenous Estradiol to Disrupt Prostate Gland Morphogenesis in Male Rat Fetuses
Toxicol. Sci., June 1, 2002; 67(2): 264 - 274.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Goyeneche, V. Calvo, G. Gibori, and C. M. Telleria
Androstenedione Interferes in Luteal Regression by Inhibiting Apoptosis and Stimulating Progesterone Production
Biol Reprod, May 1, 2002; 66(5): 1540 - 1547.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
J. R. Schwartz and S. K. Roy
Developmental Expression of Cytochrome P450 Side-Chain Cleavage and Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid and Protein in the Neonatal Hamster Ovary
Biol Reprod, December 1, 2000; 63(6): 1586 - 1593.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
P. Nokelainen, H. Peltoketo, M. Mustonen, and P. Vihko
Expression of Mouse 17{beta}-Hydroxysteroid Dehydrogenase/17-Ketosteroid Reductase Type 7 in the Ovary, Uterus, and Placenta: Localization from Implantation to Late Pregnancy
Endocrinology, February 1, 2000; 141(2): 772 - 778.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Arensburg, A. H. Payne, and J. Orly
Expression of Steroidogenic Genes in Maternal and Extraembryonic Cells During Early Pregnancy in Mice
Endocrinology, November 1, 1999; 140(11): 5220 - 5232.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
L. A. Akinola, M. Poutanen, R. Vihko, and P. Vihko
Expression of 17{beta}-Hydroxysteroid Dehydrogenase Type 1 and Type 2, P450 Aromatase, and 20{alpha}-Hydroxysteroid Dehydrogenase Enzymes in Immature, Mature, and Pregnant Rats
Endocrinology, July 1, 1997; 138(7): 2886 - 2892.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society